Meta Platforms Inc

Meta Platforms and Bristol Myers Squibb unite AI‑driven discovery with clinical expertise to accelerate oncology, hematology, and immunology therapies, a $15 billion partnership set to close 2026.

Meta Platforms’ Q1 2026 earnings reveal a strategic shift to biotech, driven by VYVGART’s expanding autoimmune sales, robust R&D, and Vision 2030 plans.

Meta’s lawsuit over its Llama AI model shows how copyright disputes can reshape content acquisition, AI infrastructure, and growth strategy.

Meta’s $13 bn “Sopaipilla” Texas data‑center: debt‑financing, AI focus, 800 MW power, 300 jobs, ESG challenges – how will it impact Meta’s future?

Meta expands Instagram and Facebook with crypto‑enabled payments, cutting fees and boosting creator payouts while scaling its CDN for low‑latency blockchain transactions.

Meta Platforms’ Q‑1 earnings show ad‑revenue growth but falling ROIC, as heavy AI spend delays profits. Investors weigh future AI value against current capital intensity and market risks.

Meta Platforms’ Q1 results reveal a shift to AI, e‑commerce, and finance as telecom‑media firms merge infrastructure and exclusive content to boost subscriber value and stay profitable amid ad‑revenue slow‑downs.

Meta Platforms’ Q1 earnings preview: how AI spending and global risks shape ad revenue, margins, and the future of its platform ecosystem.

Meta Platforms’ Q2 earnings fell short of forecasts, but its cash reserve, AI‑driven AR/VR investments, and content‑strategy give investors confidence in future growth amid 5G‑enabled media shifts.

Meta Platforms cuts 8,000 jobs and freezes 6,000 hires to boost AI investment, while launching a unified account hub that streamlines Facebook, Instagram, WhatsApp and Threads for a smoother, more integrated user experience.